SANTEN

Serial Number 79228774
Registration 5730380
739

Registration Progress

Application Filed
Feb 16, 2018
Under Examination
Approved for Publication
Feb 5, 2019
Published for Opposition
Feb 5, 2019
Registered
Apr 23, 2019

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2019-04-23) (Grace Period Filing)
Due: Oct 23, 2025 Grace Period - 80 days
Original deadline was Apr 23, 2025 (overdue)

Trademark Image

SANTEN

Basic Information

Serial Number
79228774
Registration Number
5730380
Filing Date
February 16, 2018
Registration Date
April 23, 2019
Published for Opposition
February 5, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
739
Status Date
Dec 13, 2024
Registration
Registered
Classes
005

Rights Holder

Santen Pharmaceutical Co., Ltd.

03
Address
4-20 Ofuka-cho, Kita-ku
Osaka-shi, Osaka 530-8552
JP

Ownership History

Santen Pharmaceutical Co., Ltd.

Original Applicant
03
Osaka-fu 533-8651 JP

Santen Pharmaceutical Co., Ltd.

Owner at Publication
03
Osaka-fu 533-8651 JP

Santen Pharmaceutical Co., Ltd.

Original Registrant
03
Osaka-shi, Osaka JP

Legal Representation

Attorney
John Lyhus

USPTO Deadlines

Next Deadline
In Grace Period
Section 8 (6-Year) Declaration Due (Based on registration date 2019-04-23)
Due Date
April 23, 2025
Grace Period Ends
October 23, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

34 events
Date Code Type Description Documents
Dec 13, 2024 C75A O REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. Loading...
Dec 13, 2024 NA75 E NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED Loading...
Dec 2, 2024 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Apr 25, 2024 ES75 I TEAS SECTION 71 & 15 RECEIVED Loading...
Apr 23, 2024 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Loading...
May 1, 2020 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB Loading...
Aug 30, 2019 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Aug 14, 2019 FIMP P FINAL DISPOSITION PROCESSED Loading...
Aug 14, 2019 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Jul 23, 2019 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Apr 23, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Feb 5, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 5, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 1, 2019 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Jan 16, 2019 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Jan 16, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 16, 2019 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Dec 29, 2018 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 13, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 13, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 7, 2018 ALIE A ASSIGNED TO LIE Loading...
Dec 4, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 7, 2018 CORN I CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED Loading...
Jul 13, 2018 RFNT P REFUSAL PROCESSED BY IB Loading...
Jul 13, 2018 CRCV M CORRECTION TRANSACTION RECEIVED FROM IB Loading...
Jun 18, 2018 RFRR P REFUSAL PROCESSED BY MPU Loading...
Jun 18, 2018 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Jun 9, 2018 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Jun 8, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 1, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 23, 2018 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Mar 19, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 16, 2018 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
Mar 15, 2018 SDRC M SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB Loading...

Detailed Classifications

Class 005
Collyrium; eye drops; ophthalmological preparations; pharmaceutical preparations for treatment of cataracts; pharmaceutical preparations for treatment of glaucoma; pharmaceutical preparations for treatment of ocular hypertension; ophthalmic ointments for treatment of eye disease; pharmaceutical preparations for use in eye injections; pharmaceutical preparations for treatment of pinguecula; pharmaceurical preparations for treatment of chalazion; pharmaceutical preparations for treatment of uveitis; eye drops for treatment of keratoconjunctival epithelial disorder; antibacterial eye drops; antiallergic eye drops; oiled paper for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for medical use; capsules sold empty for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive medical plasters; bandages for dressings; antiseptic liquid bandages; breast- nursing pads; dietary supplements for humans; nutritional supplements; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; food for babies; dietary supplements for animals; dental cements; materials for dental fillings and dental prostheses; dental waxes; disposable diapers for incontinence; mothproofing paper; lactose for pharmaceutical purposes

Classification

International Classes
005